NCT01367873View on ClinicalTrials.gov

Ascending Single-Dose Study to Evaluate VIA-3196 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Drug Safety
Interventions
DRUG

Placebo

Oral, matching number of placebo capsule(s) with active arm

DRUG

VIA-3196

Oral, capsule(s)

Trial Locations (1)

58104

Cetero Research, Fargo

Sponsors
All Listed Sponsors
lead

Madrigal Pharmaceuticals, Inc.

INDUSTRY

NCT01367873 - Ascending Single-Dose Study to Evaluate VIA-3196 in Healthy Subjects | Biotech Hunter | Biotech Hunter